MedPath
FDA Product

Deferiprone

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Deferiprone

51672-4196

Regulatory Information

51672-4196

ANDA208800

C73584

May 19, 2025

USA

These highlights do not include all the information needed to use DEFERIPRONE TABLETS safely and effectively. See full prescribing information for DEFERIPRONE TABLETS. DEFERIPRONE tablets, for oral use Initial U.S. Approval: 2011

HUMAN PRESCRIPTION DRUG LABEL

15

Company Information

146974886

Active Ingredients

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

DEFERIPRONE

Quantity: 500 mg in 1 1

Code: 2BTY8KH53L

Class Code: ACTIB

Active Moieties

DEFERIPRONE

Code: 2BTY8KH53L

© Copyright 2025. All Rights Reserved by MedPath